Professor and Chair
University of Houston College of Pharmacy
Disclosure(s): Acurx Pharmaceuticals: Grant/Research Support; Paratek Pharmaceuticals: Grant/Research Support; Seres Therapeutics: Grant/Research Support; Summit Pharmaceuticals: Grant/Research Support
Kevin W. Garey, PharmD, MS, FASHP, FIDSA, FCCP, BCIDP
Kevin Garey, PharmD, MS, FASHP is a Professor at the University of Houston College of Pharmacy and Chair of the Department of Pharmacy Practice and Translational Research. He is an Adjunct Professor at the University of Texas School of Public Health and a Clinical Specialist and Researcher at Baylor St. Luke’s Medical Center, Houston, Texas. He received a Bachelor of Science in Pharmacy degree from Dalhousie University in Halifax, Nova Scotia, Canada, a Doctor of Pharmacy from SUNY Buffalo in Buffalo, NY, and a Masters of Science in Biometry from the University of Texas School of Public Health. Postdoctoral training includes a pharmacy practice residency at Bassett Healthcare, Cooperstown, NY and infectious disease specialty residency and fellowship training at the University of Illinois at Chicago, Chicago, IL.
Dr. Garey is a Fellow of the Infectious Diseases Society of American (IDSA) and a member of the IDSA-Society of Healthcare Epidemiology of America (SHEA) practice guidelines for C. difficile infection. He is an active member of the Society of Infectious Diseases Pharmacists (SIDP) and a Fellow of the American Society of Health-system Pharmacists (FASHP) and American College of Clinical Pharmacy (FCCP). He has been awarded several national awards including the ASHP Best Practice Award in Health-system Pharmacy Administration (2010), the ASHP Drug Therapy Research Award (2007), the SIDP Impact Paper in Infectious Diseases Pharmacotherapy Research Award (2007, 2012) and the ACCP Russell Miller Award (2022). Dr. Garey's research is supported by the National Institute of Health, the Centers for Disease Control and Prevention, and the biotechnology industry. He has published over 240 manuscripts centered on clinical and translational research in healthcare associated infections including healthcare-related infections, candidemia, and Clostridium difficile infection.